ASP Isotopes (ASPI) Cost of Revenue (2023 - 2026)

ASP Isotopes' Cost of Revenue history runs 4 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 224.39% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $22.2 million, a 704.17% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 703.3% from the prior year.
• Cost of Revenue declined to $2.5 million in Q1 2026 per ASPI's latest filing, from $14.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $14.6 million in Q4 2025 and bottomed at $294056.0 in Q4 2023.
• The 4-year median for Cost of Revenue is $700623.5 (2025), against an average of $2.6 million.
• Biggest YoY gain for Cost of Revenue was 2376.8% in 2025; the steepest drop was 4.15% in 2025.
• Year by year, Cost of Revenue stood at $294056.0 in 2023, then surged by 100.14% to $588527.0 in 2024, then surged by 2376.8% to $14.6 million in 2025, then tumbled by 82.75% to $2.5 million in 2026.
• Per Business Quant, the three latest ASPI Cost of Revenue figures stand at $2.5 million (Q1 2026), $14.6 million (Q4 2025), and $4.5 million (Q3 2025).